Shingrix has gained an approval from China’s National Medical Products Administration (NMPA) after an expedited review, but UK-based manufacturer GlaxoSmithKline PLC says the shingles vaccine won’t be launched in the country until 2020.
Already approved elsewhere including in the US, where it was launched in 2017, and in Canada, the EU, Australia and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?